4
Changes in Ownership
RxSight, Inc. Filed Acc 0001193125-26-031826
Options or other derivatives
- Chief Financial Officer acquired 422,298 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Wilterding Mark Chief Financial Officer | 2026-01-12 | Grant or award · Stock Option (right to buy) | +258,770 | 258,770 | D | ||
| Wilterding Mark Chief Financial Officer | 2026-01-12 | Grant or award · Restricted Stock Unit | +163,528 | 163,528 | D | ||
Loading xslF345X05/ownership.xml…